(Q34786857)

English

Pathologic evidence of dose-response and dose-volume relationships for prostate cancer treated with combined external beam radiotherapy and high-dose-rate brachytherapy

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Pathologic evidence of dose-response and dose-volume relationships for prostate cancer treated with combined external beam radiotherapy and high-dose-rate brachytherapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

adaptive radiation therapy

0 references

1 reference

based on heuristic

inferred from title

prostate cancer

1 reference

based on heuristic

inferred from title

author name string

Larry L Kestin

1

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Neal S Goldstein

2

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Frank A Vicini

3

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Christina Mitchell

4

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Gary S Gustafson

5

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Jannifer S Stromberg

6

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Peter Y Chen

7

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Alvaro A Martinez

8

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

language of work or name

0 references

publication date

1 September 2002

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

International Journal of Radiation Oncology Biology Physics

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

54

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

107-118

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Defining a dose-response relationship with radiotherapy for prostate cancer: is more really better?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902925-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of dose on local control of prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902925-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose selection for prostate cancer patients based on dose comparison and dose response studies

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902925-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Defining the optimal radiation dose with three-dimensional conformal radiation therapy for patients with nonmetastatic prostate carcinoma by using recursive partitioning techniques.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902925-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Higher than standard radiation doses (> or =72 Gy) with or without androgen deprivation in the treatment of localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902925-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Importance of high radiation doses (72 Gy or greater) in the treatment of stage T1-T3 adenocarcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902925-5

7 January 2021

based on heuristic

inferred from DOI database lookup

External beam radiotherapy dose response characteristics of 1127 men with prostate cancer treated in the PSA era

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902925-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Preliminary results of a randomized radiotherapy dose-escalation study comparing 70 Gy with 78 Gy for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902925-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Survival advantage from higher-dose radiation therapy for clinically localized prostate cancer treated on the Radiation Therapy Oncology Group trials

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902925-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902925-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Matched-pair analysis of conformal high-dose-rate brachytherapy boost versus external-beam radiation therapy alone for locally advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902925-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A dose-response study for I-125 prostate implants

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902925-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term results of retropubic permanent 125iodine implantation of the prostate for clinically localized prostatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902925-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Caution in interpreting biochemical control rates after treatment of prostate cancer: length of follow-up influences results

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902925-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Defining biochemical cure for prostate carcinoma patients treated with external beam radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902925-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Practical application of biochemical failure definitions: what to do and when to do it

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902925-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The importance of adequate follow-up in defining treatment success after external beam irradiation for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902925-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The correlation of serial prostate specific antigen measurements with clinical outcome after external beam radiation therapy of patients for prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902925-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The impact of irregularly rising prostate-specific antigen and “impending failure” on the apparent outcome of localized prostate cancer following radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902925-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Definitions of biochemical failure in prostate cancer following radiation therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902925-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Changes in biochemical disease-free survival rates as a result of adoption of the consensus conference definition in patients with clinically localized prostate cancer treated with external-beam radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902925-5

7 January 2021

based on heuristic

inferred from DOI database lookup

PSA-based outcome analysis after radiation therapy for prostate cancer: a new definition of biochemical failure after intervention

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902925-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The definition of biochemical failure in patients treated with definitive radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902925-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Advanced prostate cancer: the results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902925-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Proliferative cell nuclear antigen in postradiotherapy prostate biopsies

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902925-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Postradiotherapy prostate biopsies: what do they really mean? Results for 498 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902925-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Routine prostate biopsies following radiotherapy for prostate cancer: results for 226 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902925-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Histopathologic effects of three-dimensional conformal external beam radiation therapy on benign and malignant prostate tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902925-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Posttreatment biopsy results following interstitial brachytherapy in early-stage prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902925-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Interim report of image-guided conformal high-dose-rate brachytherapy for patients with unfavorable prostate cancer: the William Beaumont phase II dose-escalating trial

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902925-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose fractionation, dose rate and iso-effect relationships for normal tissue responses.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902925-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Fractionation and protraction for radiotherapy of prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902925-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Direct evidence that prostate tumors show high sensitivity to fractionation (low alpha/beta ratio), similar to late-responding normal tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902925-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A simple analytic derivation suggests that prostate cancer alpha/beta ratio is low

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902925-5

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro radiation sensitivity of the LNCaP prostatic tumor cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902925-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Relationship between perineural tumor invasion on needle biopsy and radical prostatectomy capsular penetration in clinical stage B adenocarcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902925-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The histology of radiation therapy effect on prostate adenocarcinoma as assessed by needle biopsy after brachytherapy boost. Correlation with biochemical failure

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902925-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902925-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum prostate-specific antigen profile following radiotherapy for prostate cancer: implications for patterns of failure and definition of cure

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902925-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A method for determining a prostate-specific antigen cure after radiation therapy for clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902925-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate-specific antigen following radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902925-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessment of endpoints for clinical trials for localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902925-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Immediate versus deferred treatment for advanced prostatic cancer: initial results of the Medical Research Council trial

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902925-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and Goserelin

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902925-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Combined orchiectomy and external radiotherapy versus radiotherapy alone for nonmetastatic prostate cancer with or without pelvic lymph node involvement: a prospective randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902925-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Subset analysis of RTOG 85-31 and 86-10 indicates an advantage for long-term vs. short-term adjuvant hormones for patients with locally advanced nonmetastatic prostate cancer treated with radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902925-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Beneficial effect of combination hormonal therapy administered prior and following external beam radiation therapy in localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902925-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Updated results of the phase III Radiation Therapy Oncology Group (RTOG) trial 85-31 evaluating the potential benefit of androgen suppression following standard radiation therapy for unfavorable prognosis carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902925-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902925-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III radiation therapy oncology group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902925-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Bicalutamide (Casodex) 150 mg as immediate therapy in patients with localized or locally advanced prostate cancer significantly reduces the risk of disease progression

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902925-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjuvant estrogen following radiation therapy for stage C adenocarcinoma of the prostate: long-term results of a prospective randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902925-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical dose-response curves of human malignant epithelial tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902925-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Histologic differentiation, cancer volume, and pelvic lymph node metastasis in adenocarcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902925-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical utility of the percentage of positive prostate biopsies in defining biochemical outcome after radical prostatectomy for patients with clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902925-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination of the preoperative PSA level, biopsy gleason score, percentage of positive biopsies, and MRI T-stage to predict early PSA failure in men with clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902925-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The clinical utility of the percent of positive prostate biopsies in predicting biochemical outcome following external-beam radiation therapy for patients with clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902925-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of systematic biopsy results to predict pathologic stage in patients with clinically localized prostate cancer: a preliminary report.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902925-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of transrectal ultrasound-guided biopsy-based staging, preoperative serum prostate-specific antigen, and biopsy Gleason score in prediction of final pathologic diagnosis in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902925-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Sextant prostate biopsies. A histopathologic correlation with radical prostatectomy specimens

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902925-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Positive fraction of systematic biopsies predicts risk of relapse after radical prostatectomy.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902925-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Predicting prostate carcinoma volume and stage at radical prostatectomy by assessing needle biopsy specimens for percent surface area and cores positive for carcinoma, perineural invasion, Gleason score, DNA ploidy and proliferation, and preoperativ

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902925-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Prediction of prostate cancer volume using prostate-specific antigen levels, transrectal ultrasound, and systematic sextant biopsies

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902925-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Ability of sextant biopsies to predict radical prostatectomy stage

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902925-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose escalation with 3D-CRT in prostate cancer: French study of dose escalation with conformal 3D radiotherapy in prostate cancer-preliminary results

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902925-5

7 January 2021

based on heuristic

inferred from DOI database lookup

3D conformal radiation therapy (3DCRT) for high grade prostate cancer: a multi-institutional review

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902925-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiation dose response in patients with favorable localized prostate cancer (Stage T1-T2, biopsy Gleason < or = 6, and pretreatment prostate-specific antigen < or = 10)

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902925-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiotherapy for high grade clinically localized adenocarcinoma of the prostate.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902925-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0360-3016(02)02925-5

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34786857&oldid=1856145087"